About Validant
Validant is a Healthcare company based in San Francisco (United States) founded in 2005, and was acquired by GHO Capital Partners in December 2018. Regulatory, compliance, and quality consulting for GxP lifecycles is provided. Validant has raised $2.28 million across 3 funding rounds from investors including Permira and GHO Capital. Validant has completed 6 acquisitions, including Clinical Outcomes Solutions, DataRevive and Eliquent Japan. Validant offers products and services including Strategic Consulting, Execution Services, and Ongoing Support. Its focus areas include Biopharma Outsourcing, Consulting and Regulatory Affairs. Its legal entity is Kinsale Holdings, Inc. Its competitors include ProPharma Group, Technical Safety Services and Celegence.
Company details
Validant was founded in 2005 and is headquartered in San Francisco, United States. Services in regulatory compliance and quality consulting are offered across pharmaceuticals, biologics, medical devices, diagnostics, and gene and cell therapies. Operations cover preclinical, clinical, manufacturing, and distribution phases of GxP product lifecycles. Strategic planning, implementation, and ongoing maintenance support are provided to navigate approvals and ensure product integrity.
- Headquarters San Francisco, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website validant.com
- Social LinkedIn X Facebook
- Acquired by GHO Capital Partners (Dec 2018)
- Legal Name Kinsale Holdings, Inc.
- Total Equity Funding$2.28M (USD)
in 3 rounds
- InvestorsPermira
& 1 more
- Investments & AcquisitionsClinical Outcomes Solutions
& 5 more
- Acquired byGHO Capital Partners
(Dec 2018)
Products & Services of Validant
Validant offers a comprehensive portfolio of products and services, including Strategic Consulting, Execution Services, and Ongoing Support.
Develops strategies for regulatory compliance and business needs
Deploys teams for hands-on strategy execution
Offers training and monitoring for sustained compliance
Funding Insights of Validant
Validant has successfully raised a total of $2.28M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $2.28M
- Total Rounds 3
- First Round $765,000
(Jun 2011)
- Investors Count 1
All 3 funding rounds of Validant with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2018 | Debt – Conventional | – | – | ||
| Feb 2012 | $1.51M | Series A | – | – | – |
| Jun 2011 | $765,000 | Seed | – | – | – |
2 investors in total: 2 institutional.
Investors in Validant
Validant has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Permira and GHO Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investments are made in technology, consumer, healthcare, and service sectors. | 1985 | permira.com | London, United Kingdom | |
Specialist healthcare investment advisory services are provided by GHO Capital. | ghocapital.com | London, United Kingdom |
Investor details for Validant
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Validant
52 people are tracked at Validant (11 in leadership, 41 in team).
| Name | Role | Group |
|---|---|---|
Heidi H. | Director Business Development West | Leadership |
Barbara Clendenen | Chief Business Development Officer | Leadership |
Derek Jacobson | Director Of Enterprise Business Applications | Leadership |
Eileen Valenta | VP Regulatory Affairs And Client Services | Leadership |
Tim Dietlin | CEO of the Validant Group | Leadership |
Johnny Long | Corporate Vice President | Leadership |
Kurt Moerck | Partner - Gxp Quality, Compliance & Regulatory Specialist | Leadership |
Nathaniel Cartagena | Chief Information Officer | Leadership |
Stephanie Colotti | Vice President, Client Services | Leadership |
Fcipd Martyn Edney | Chief Human Resources Officer | Leadership |
Jeffrey Wallace | Senior Director Program Management | Leadership |
Erick Carleton | Systems Admin | Team |
Tejon Anthony | Information Technology Operations Administrator | Team |
Isaiah Fuller | Pharma/biotech Consultant | Team |
Khyati Patel | Operations Manager Business Development | Team |
Manuel Pol | Senior Consultant | Team |
Sean O'Brien | Senior Qc/qa Consultant | Team |
Stuart R. | Project Engineer And Principal Consultant | Team |
Masaru Kobayashi | Consultant | Team |
Marshall Thompson Asq Cpgp | Regulatory/compliance/quality Consultant | Team |
32 more people are available in the full profile.
Complete people profiles for Validant
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Validant
Validant has strategically engaged in corporate development activities, having acquired 6 companies. Notable acquisitions include Clinical Outcomes Solutions, DataRevive and Eliquent Japan.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Regulatory support and consulting services are provided for clinical outcomes. | clinoutsolutions.com | Tucson, United States | 2013 | May 2021 | •••• | |
Regulatory consulting services are provided to medical device companies. | greenleafhealth.com | 2007 | Apr 2021 | •••• | ||
Medical devices regulatory training, consulting, and auditing services are provided. | orielstat.com | Union, United States | 1968 | Dec 2020 | •••• | |
Industrial automation and control products are manufactured by IDEC. | idec.com | Osaka, Japan | 1945 | Nov 2020 | •••• | |
Regulatory and consulting services are provided to the biopharma sector. | idec-inc.com | Shinjuku, Japan | 2003 | Nov 2020 | •••• | |
CMC, nonclinical, and clinical regulatory consulting for biologics is provided. | data-revive.com | Potomac, United States | 2016 | Nov 2019 | •••• |
Complete acquisition details for Validant
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Validant
10 dated milestones of Validant across 16 years, from founding to its latest funding, stage changes and deals.
- Founded Validant is founded.
- Funding First funding round of $765K.
- Exit Acquired by GHO Capital Partners.
- Funding Latest funding round, Debt – Conventional,.
- Acquisition Acquires DataRevive.
- Acquisition Acquires Eliquent Japan.
- Acquisition Acquires IDEC Corporation.
- Acquisition Acquires Oriel STAT A MATRIX.
- Acquisition Acquires Greenleaf Health.
- Acquisition Acquires Clinical Outcomes Solutions.
Competitors of Validant
Validant has 3 listed competitors in our database. They include ProPharma Group, Technical Safety Services and Celegence.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| propharmagroup.com | 2001 | Saint Paul, United States | 999 | Provider of regulatory compliance solutions to pharmaceutical, biotechnology and medical device | ||
| techsafety.com | 1970 | Berkeley, United States | 71 | Healthcare instrumentation, medical gas systems, and related devices are manufactured. | ||
| celegence.com | 2017 | Downers Grove, United States | Regulatory consulting and solutions for pharmaceuticals and medical devices compliance. |
Detailed competitors of Validant
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Validant
The website of Validant (validant.com) receives about 1.7K visits a month.
- Monthly visits1.7K
▲ 22.3% vs previous month
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Validant (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Validant
Complete news archive for Validant
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Validant
Validant was founded in 2005 and raised its 1st funding round 6 years after it was founded.
Validant is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Validant is a funded company, having raised a total of $2.28M across 3 funding rounds to date. The company's 1st funding round was a Seed of $765K, raised on Jun 2011.
Validant was founded in 2005 and is headquartered in San Francisco, United States. Services in regulatory compliance and quality consulting are offered across pharmaceuticals, biologics, medical devices, diagnostics, and gene and cell therapies. Operations cover preclinical, clinical, manufacturing, and distribution phases of GxP product lifecycles. Strategic planning, implementation, and ongoing maintenance support are provided to navigate approvals and ensure product integrity.
Validant's top competitors include ProPharma Group, Technical Safety Services and Celegence.
Validant offers Strategic Consulting, Execution Services, and Ongoing Support.
Validant has made 6 acquisitions, including Clinical Outcomes Solutions, DataRevive, and Eliquent Japan.
Validant has 2 investors. Key investors include Permira, and GHO Capital.
Validant operates through Kinsale Holdings, Inc..
Yes. Validant was acquired by GHO Capital Partners in December 2018.